Try our mobile app

ИНН: 9704005675

E-disclosure page: 38507

Рост выручки hist 0.0%
Рост EBITDA hist 0.0%

Net Debt / Total Equity 0.0x
EBIT / Interest Payment 0.8x

млн руб
LTM Выручка 0
LTM EBITDA 0
LTM Операционная прибыль 4 858
LTM Чистая прибыль -1 114

Собственный капитал 27 486
Interest payment 6 176

Выручка и EBITDA

Квартальные значения (млн руб)

Изменения (г/г)

Денежный поток

FCF (млн руб) до искл. курс. разниц

Чистый долг / денежные средства (млн руб)

Облигации
Название ISIN Тип Доходность Валюта Цена Объем торгов (млн р.) Купон Ставка купона Премия Дата погашения/оферты Дюрация, лет
БинФарм1P3 RU000A107E81 плав +24.0% RUB 99.6% 0.62 0.0 0.0% +2.2% 2026-12-14 1.3
БинФарм1P6 RU000A10BZT3 плав +18.7% RUB 102.8% 1.82 16.0 19.5% - 2027-01-13 1.4
БинФарм1P4 RU000A10AS28 фикс +18.5% RUB 107.5% 1.13 21.0 25.5% - 2026-08-05 1.0
БинФарм1P5 RU000A10B3Q2 фикс +17.7% RUB 107.1% 0.25 19.3 23.5% - 2026-09-16 1.1
БинФарм1P1 RU000A1043Z7 плав +9.3% RUB 103.9% 0.01 57.3 23.0% -1.1% 2025-11-24 0.3
БинФарм1P2 RU000A104Z71 плав -7.0% RUB 105.9% 0.19 57.3 23.0% -0.4% 2025-10-21 0.2
MSFO data *The values are shown in mln RUB The % change shows the difference from the same period last year

export to csv



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2024 q4 9 185+13%   1 556+54% -70<-100% 44+104% -1 653+88%
2024 q3 9 185+13%   1 556+54% -70<-100% 44+104% -1 653+88%
2024 q2 7 638+10%   873-20% -487<-100% 34+144% -1 435+90%
2024 q1 7 638+10%   873-20% -487<-100% 34+144% -1 435+90%
2023 q4 8 135+16%   1 011-13% 77-80% 22-34% -878+27%
2023 q3 8 135+16%   1 011-13% 77-80% 22-34% -878+27%
2023 q2 6 955+10%   1 094+8% 253-26% 14-59% -754+31%
2023 q1 6 955+10%   1 094+8% 253-26% 14-59% -754+31%
2022 q4 7 010+12%   1 167+17% 380-32% 33+123% -692+124%
2022 q3 7 010+12%   1 167+17% 380-32% 33+123% -692+124%
2022 q2 6 306   1 010 343 34 -575
2022 q1 6 306   1 010 343 34 -575
2021 q4 6 285   998 556 15 -309
2021 q3 6 285   998 556 15 -309
2021 q2            
2020 q4            
2020 q3            
2019 q4     0 0    
2019 q3     0 0    


Balance


Implied interest rate for 2024 q4:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (1 653 - 44) * 4 / (22 730 - 466)

Q Total equity Total assets Net debt Implied interest rate
 
2024 q4 27 486-16% 74 107+3% 22 730+44% 28.9%
2024 q3        
2024 q2 29 772-9% 70 981+10% 19 919+30% 28.8%
2024 q1        
2023 q4 32 632+1% 72 065+14% 15 767-6% 22.4%
2023 q3        
2023 q2 32 831-4% 64 742+2% 15 289-15% 19.9%
2023 q1        
2022 q4 32 406-3% 63 067+15% 16 760+57% 16.2%
2022 q3        
2022 q2 34 199 63 587 18 066 12.4%
2022 q1        
2021 q4 33 446 54 883>+200% 10 650 11.7%
2021 q3        
2021 q2        
2020 q4   0>+200%    
2020 q3        
2019 q4   0 0  
2019 q3        


Cashflow


Q Operating cashflow Investing cashflow Financial cashflow
 
2024 q4 804-29% -1 046+18% 46<-100%
2024 q3 804-21% -1 046+9% 46-85%
2024 q2 167-88% -1 187+90% 381<-100%
2024 q1 167-88% -1 187+90% 381<-100%
2023 q4 1 137+21% -884+11% -4-98%
2023 q3 1 023+9% -958+20% 309<-100%
2023 q2 1 442<-100% -626-51% -944<-100%
2023 q1 1 442<-100% -626-51% -944<-100%
2022 q4 941+2% -800>+200% -240-8%
2022 q3 941+2% -800>+200% -240-23%
2022 q2 -2 254<-100% -1 286>+200% 3 240<-100%
2022 q1 -2 254 -1 286 3 240
2021 q4 922<-100% -186+2% -262+148%
2021 q3 921<-100% -225 -312
2021 q2 924 -71 -111
2020 q4 0>+200% -182 -106
2020 q3 0>+200%    
2019 q4 0    
2019 q3 0    
RSBU data *The values are shown in mln RUB The % change shows the difference from the same period last year

export to csv



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2025 q1 5 553-46% 1 118-79% -1 093<-100% -2 234>+200% 300+126% -1 334>+200%
2024 q4 -33 609<-100%          
2024 q3 16 726+44% 9 388+51% 1 214+45% -115<-100% 127+25% -569+109%
2024 q2 15 140+54% 8 807+40% 188-95% -670<-100% 113+27% -451+85%
2024 q1 10 283+7% 5 351+30% 171>+200% -654+111% 132+37% -436+63%
2023 q4 13 825+33% 7 362+40% 1 257-14% -305<-100% 101-6% -330+14%
2023 q3 11 589+21% 6 233+49% 838-21% 157-71% 102+24% -272+2%
2023 q2 9 841+24% 6 288+58% 3 482<-100% 4 057>+200% 89+44% -243+40%
2023 q1 9 612+12% 4 126+47% 53-95% -310<-100% 97+17% -267+157%
2022 q4 10 374>+200% 5 258>+200% 1 456<-100% 3 124<-100% 108>+200% -290>+200%
2022 q3 9 607>+200% 4 189>+200% 1 067<-100% 542-65% 82 -266
2022 q2 7 929>+200% 3 983 -751>+200% 925<-100% 62 -174
2022 q1 8 601+100% 2 811 1 091<-100% 1 131<-100% 83 -104
2021 q4 140 100 -605 -500 8 -31
2021 q3 13 12 -6 1 549    
2021 q2 1   -3 -3    
2021 q1 0   0 -814    
2020 q4            


Balance


Implied interest rate for 2025 q1:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (1 334 - 300) * 4 / (23 964 - 0)

Q Total equity Total assets Net debt
 
2025 q1 34 476-22% 91 435+12% 23 964+174%
2024 q4     15 866+120%
2024 q3 38 347-15% 80 899+5% 17 002+70%
2024 q2 41 462-8% 79 727-6% 12 213+136%
2024 q1 44 132+8% 81 615+2% 8 755+65%
2023 q4 44 786+9% 81 205+7% 7 228+27%
2023 q3 45 091+11% 76 920+6% 9 974+135%
2023 q2 44 935+12% 84 851+26% 5 177+31%
2023 q1 40 877+5% 79 841+37% 5 314+184%
2022 q4 41 188+8% 75 781+82% 5 708<-100%
2022 q3 40 565+7% 72 564+74% 4 239
2022 q2 40 023+5% 67 252+61% 3 940
2022 q1 39 097+3% 58 079+39% 1 872
2021 q4 37 966>+200% 41 734>+200% -341>+200%
2021 q3 37 966 41 734  
2021 q2 37 966 41 734  
2021 q1 37 966 41 734  
2020 q4 0 0 0

Financial reports

RAS reports